$CVS
CVS Health Corp

2014 Q2 Form 10-Q Financial Statement

#000006480314000028 Filed on August 05, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2013 Q2
Revenue $34.60B $31.25B
YoY Change 10.73% 1.8%
Cost Of Revenue $28.28B $25.41B
YoY Change 11.3% 0.56%
Gross Profit $6.324B $5.841B
YoY Change 8.27% 7.31%
Gross Profit Margin 18.28% 18.69%
Selling, General & Admin $4.116B $3.869B
YoY Change 6.38% 3.42%
% of Gross Profit 65.09% 66.24%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $4.116B $3.869B
YoY Change 6.38% 3.42%
Operating Profit $2.208B $1.972B
YoY Change 11.97% 15.86%
Interest Expense $161.0M $127.0M
YoY Change 26.77% -3.79%
% of Operating Profit 7.29% 6.44%
Other Income/Expense, Net
YoY Change
Pretax Income $2.050B $1.846B
YoY Change 11.05% 17.13%
Income Tax $804.0M $721.0M
% Of Pretax Income 39.22% 39.06%
Net Earnings $1.246B $1.124B
YoY Change 10.85% 16.96%
Net Earnings / Revenue 3.6% 3.6%
Basic Earnings Per Share $1.07 $0.92
Diluted Earnings Per Share $1.06 $0.91
COMMON SHARES
Basic Shares Outstanding 1.165B shares 1.227B shares
Diluted Shares Outstanding 1.174B shares 1.236B shares

Balance Sheet

Concept 2014 Q2 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.712B $1.179B
YoY Change 45.21% -35.5%
Cash & Equivalents $1.612B $1.174B
Short-Term Investments $100.0M $5.000M
Other Short-Term Assets $554.0M $413.0M
YoY Change 34.14% -55.06%
Inventory $11.36B $10.58B
Prepaid Expenses
Receivables $9.533B $7.093B
Other Receivables $0.00 $0.00
Total Short-Term Assets $24.14B $19.87B
YoY Change 21.49% 2.95%
LONG-TERM ASSETS
Property, Plant & Equipment $8.820B $8.708B
YoY Change 1.29% 1.09%
Goodwill $28.13B $26.55B
YoY Change 5.92% 0.49%
Intangibles $9.906B $9.657B
YoY Change 2.58%
Long-Term Investments
YoY Change
Other Assets $1.603B $1.496B
YoY Change 7.15% 10.0%
Total Long-Term Assets $48.46B $46.42B
YoY Change 4.4% 0.27%
TOTAL ASSETS
Total Short-Term Assets $24.14B $19.87B
Total Long-Term Assets $48.46B $46.42B
Total Assets $72.59B $66.28B
YoY Change 9.52% 1.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.780B $5.178B
YoY Change 11.63% -39.45%
Accrued Expenses $4.812B $3.501B
YoY Change 37.45% -20.07%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $1.119B $18.00M
YoY Change 6116.67% 260.0%
Total Short-Term Liabilities $16.63B $12.69B
YoY Change 31.04% -3.4%
LONG-TERM LIABILITIES
Long-Term Debt $12.25B $9.358B
YoY Change 30.93% 1.63%
Other Long-Term Liabilities $1.489B $1.534B
YoY Change -2.93% 6.68%
Total Long-Term Liabilities $1.489B $10.89B
YoY Change -86.33% 2.31%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.63B $12.69B
Total Long-Term Liabilities $1.489B $10.89B
Total Liabilities $18.12B $23.58B
YoY Change -23.17% -14.79%
SHAREHOLDERS EQUITY
Retained Earnings $30.22B $26.57B
YoY Change 13.73%
Common Stock $17.00M $17.00M
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $22.13B $16.99B
YoY Change 30.28%
Treasury Stock Shares 527.0M shares 448.0M shares
Shareholders Equity $38.13B $38.91B
YoY Change
Total Liabilities & Shareholders Equity $72.59B $66.28B
YoY Change 9.52% 1.06%

Cashflow Statement

Concept 2014 Q2 2013 Q2
OPERATING ACTIVITIES
Net Income $1.246B $1.124B
YoY Change 10.85% 16.96%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $897.0M $902.0M
YoY Change -0.55% -26.73%
INVESTING ACTIVITIES
Capital Expenditures -$503.0M -$486.0M
YoY Change 3.5% 9.95%
Acquisitions
YoY Change
Other Investing Activities -$122.0M -$40.00M
YoY Change 205.0% -80.0%
Cash From Investing Activities -$625.0M -$526.0M
YoY Change 18.82% -18.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.423B -751.0M
YoY Change 89.48% -23.13%
NET CHANGE
Cash From Operating Activities 897.0M 902.0M
Cash From Investing Activities -625.0M -526.0M
Cash From Financing Activities -1.423B -751.0M
Net Change In Cash -1.151B -375.0M
YoY Change 206.93% -3.35%
FREE CASH FLOW
Cash From Operating Activities $897.0M $902.0M
Capital Expenditures -$503.0M -$486.0M
Free Cash Flow $1.400B $1.388B
YoY Change 0.86% -17.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-139000000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-181000000 USD
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-182000000 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
29777000000 USD
CY2014Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
30186000000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4500000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2200000 shares
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5548000000 USD
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5780000000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8729000000 USD
CY2014Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9533000000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4768000000 USD
CY2014Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4812000000 USD
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-132000000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-149000000 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-198000000 USD
CY2014Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4100000 shares
CY2013Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8400000 shares
CY2013Q4 us-gaap Assets
Assets
71526000000 USD
CY2014Q2 us-gaap Assets
Assets
72593000000 USD
CY2014Q2 us-gaap Assets Current
AssetsCurrent
24138000000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
25325000000 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1612000000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4089000000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1375000000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1174000000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-201000000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2477000000 USD
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.450
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.550
CY2013Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.225
CY2014Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.275
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
2.01
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3200000000 shares
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3200000000 shares
CY2013Q4 us-gaap Common Stock Shares Held In Employee Trust
CommonStockSharesHeldInEmployeeTrust
31000000 USD
CY2014Q2 us-gaap Common Stock Shares Held In Employee Trust
CommonStockSharesHeldInEmployeeTrust
31000000 USD
CY2013Q4 us-gaap Common Stock Shares Held In Employee Trust Shares
CommonStockSharesHeldInEmployeeTrustShares
1000000 shares
CY2014Q2 us-gaap Common Stock Shares Held In Employee Trust Shares
CommonStockSharesHeldInEmployeeTrustShares
1000000 shares
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1688000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1680000000 shares
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1160000000 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1180000000 shares
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
17000000 USD
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
17000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2392000000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1108000000 USD
CY2014Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1253000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2061000000 USD
CY2013Q2 us-gaap Cost Of Revenue
CostOfRevenue
25407000000 USD
us-gaap Cost Of Revenue
CostOfRevenue
55025000000 USD
CY2014Q2 us-gaap Cost Of Revenue
CostOfRevenue
28278000000 USD
us-gaap Cost Of Revenue
CostOfRevenue
50581000000 USD
CY2014Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
13400000000 USD
CY2014Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
979000000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
902000000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
3901000000 USD
CY2014Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
4091000000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
951000000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
965000000 USD
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.07
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.92
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.69
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.03
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.68
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.01
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.91
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-2000000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-3000000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
65000000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
34000000 USD
CY2014Q2 us-gaap Goodwill
Goodwill
28126000000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
26542000000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
1576000000 USD
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-1000000 USD
us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
9000000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
5841000000 USD
us-gaap Gross Profit
GrossProfit
12266000000 USD
us-gaap Gross Profit
GrossProfit
11418000000 USD
CY2014Q2 us-gaap Gross Profit
GrossProfit
6324000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3916000000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1846000000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2050000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3414000000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1125000000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1246000000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2079000000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2375000000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.92
CY2014Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.07
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.69
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
2.03
CY2013Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.91
CY2014Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.06
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.68
CY2014Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-1000000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 USD
CY2013Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-1000000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
CY2014Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
CY2013Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
CY2013Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
CY2014Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
721000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1335000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1541000000 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
804000000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
1530000000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
1483000000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
521000000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
98000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
575000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
584000000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-401000000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
33000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-192000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
235000000 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
74000000 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-165000000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
138000000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
23000000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-30000000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
24000000 USD
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
8000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
7000000 shares
CY2013Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
8000000 shares
CY2014Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
8000000 shares
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9529000000 USD
CY2014Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9906000000 USD
us-gaap Interest Expense
InterestExpense
322000000 USD
us-gaap Interest Expense
InterestExpense
254000000 USD
CY2014Q2 us-gaap Interest Expense
InterestExpense
161000000 USD
CY2013Q2 us-gaap Interest Expense
InterestExpense
127000000 USD
CY2014Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-158000000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-252000000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-316000000 USD
CY2013Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-126000000 USD
us-gaap Interest Paid
InterestPaid
267000000 USD
us-gaap Interest Paid
InterestPaid
331000000 USD
CY2014Q2 us-gaap Inventory Net
InventoryNet
11360000000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
11045000000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
2000000 USD
CY2013Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
6000000 USD
CY2014Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
3000000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
71526000000 USD
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
72593000000 USD
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
16629000000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
15425000000 USD
CY2014Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
14700000000 USD
CY2003Q4 us-gaap Loss Contingency Number Of Defendants
LossContingencyNumberOfDefendants
2 entity
CY2014Q2 us-gaap Minority Interest
MinorityInterest
2000000 USD
CY2013Q4 us-gaap Minority Interest
MinorityInterest
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2358000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1648000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3185000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1093000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3069000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2542000000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
us-gaap Operating Expenses
OperatingExpenses
7752000000 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
3869000000 USD
us-gaap Operating Expenses
OperatingExpenses
8034000000 USD
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
4116000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
4232000000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1972000000 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
2208000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
3666000000 USD
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
472000000 USD
CY2014Q2 us-gaap Other Assets Current
OtherAssetsCurrent
554000000 USD
CY2014Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1603000000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1515000000 USD
CY2014Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
6000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
15000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-18000000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-16000000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-16000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-17000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
17000000 USD
CY2014Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
7000000 USD
CY2013Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
0 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
1000000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
2000000 USD
CY2014Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
1000000 USD
CY2014Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1489000000 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1421000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
748000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2001000000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
647000000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
553000000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
0 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
161000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2248000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
300000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
891000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
804000000 USD
us-gaap Payments To Suppliers
PaymentsToSuppliers
44657000000 USD
us-gaap Payments To Suppliers
PaymentsToSuppliers
50268000000 USD
us-gaap Payments To Suppliers And Employees
PaymentsToSuppliersAndEmployees
7452000000 USD
us-gaap Payments To Suppliers And Employees
PaymentsToSuppliersAndEmployees
7787000000 USD
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000.0 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000.0 shares
CY2014Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
7000000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
266000000 USD
CY2014Q2 us-gaap Profit Loss
ProfitLoss
1246000000 USD
us-gaap Profit Loss
ProfitLoss
2078000000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8615000000 USD
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8820000000 USD
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
us-gaap Proceeds From Customers
ProceedsFromCustomers
56446000000 USD
us-gaap Proceeds From Customers
ProceedsFromCustomers
62932000000 USD
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
6000000 USD
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
2000000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
0 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-690000000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
0 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
103000000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
11000000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
309000000 USD
CY2013Q2 us-gaap Profit Loss
ProfitLoss
1124000000 USD
us-gaap Profit Loss
ProfitLoss
2375000000 USD
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-1000000 USD
CY2014Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-1000000 USD
CY2013Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
0 USD
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-2000000 USD
CY2013Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
10000000 USD
CY2014Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
11000000 USD
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
27000000 USD
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
23000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
41000000 USD
us-gaap Restricted Stock Expense
RestrictedStockExpense
27000000 USD
CY2014Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
18000000 USD
us-gaap Restricted Stock Expense
RestrictedStockExpense
18000000 USD
CY2013Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
10000000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
28493000000 USD
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
30221000000 USD
CY2014Q2 us-gaap Revenues
Revenues
34602000000 USD
us-gaap Revenues
Revenues
61999000000 USD
us-gaap Revenues
Revenues
67291000000 USD
CY2013Q2 us-gaap Revenues
Revenues
31248000000 USD
us-gaap Sale Leaseback Transaction Net Proceeds
SaleLeasebackTransactionNetProceeds
0 USD
us-gaap Sale Leaseback Transaction Net Proceeds
SaleLeasebackTransactionNetProceeds
5000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
77000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
66000000 USD
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4000000 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
11.26
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
32000000 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
46.49
CY2014Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
74.29
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y5M15D
CY2013Q4 us-gaap Short Term Investments
ShortTermInvestments
88000000 USD
CY2014Q2 us-gaap Short Term Investments
ShortTermInvestments
100000000 USD
CY2013Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
22000000 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
50000000 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
48000000 USD
CY2014Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
24000000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
37938000000 USD
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
38130000000 USD
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
37938000000 USD
CY2014Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
38132000000 USD
CY2014Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
527000000 shares
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
500000000 shares
CY2013Q4 us-gaap Treasury Stock Value
TreasuryStockValue
20169000000 USD
CY2014Q2 us-gaap Treasury Stock Value
TreasuryStockValue
22131000000 USD
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1174000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1182000000 shares
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1236000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1238000000 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1165000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1172000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1230000000 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1227000000 shares
CY2013Q4 cvs Claims And Discounts Payable
ClaimsAndDiscountsPayable
4548000000 USD
CY2014Q2 cvs Claims And Discounts Payable
ClaimsAndDiscountsPayable
4918000000 USD
cvs Deferred Income Tax Expense Benefit And Other Non Cash Items
DeferredIncomeTaxExpenseBenefitAndOtherNonCashItems
82000000 USD
cvs Deferred Income Tax Expense Benefit And Other Non Cash Items
DeferredIncomeTaxExpenseBenefitAndOtherNonCashItems
44000000 USD
CY2014Q2 cvs Guaranteed Store Leases
GuaranteedStoreLeases
72 store_lease
cvs Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
2000000 shares
cvs Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
1000000 shares
CY2013Q2 cvs Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
1000000 shares
CY2014Q2 cvs Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
1000000 shares
cvs Intersegment Transactions Number Of Type Of Transactions
IntersegmentTransactionsNumberOfTypeOfTransactions
2 type_of_transaction
CY2013Q4 cvs Longtermdebtcurrentmaturitiesincludingcapitalleases
Longtermdebtcurrentmaturitiesincludingcapitalleases
561000000 USD
CY2014Q2 cvs Longtermdebtcurrentmaturitiesincludingcapitalleases
Longtermdebtcurrentmaturitiesincludingcapitalleases
1119000000 USD
CY2013Q4 cvs Longtermdebtexcludingcurrentmaturitiesincludingcapitalleases
Longtermdebtexcludingcurrentmaturitiesincludingcapitalleases
12841000000 USD
CY2014Q2 cvs Longtermdebtexcludingcurrentmaturitiesincludingcapitalleases
Longtermdebtexcludingcurrentmaturitiesincludingcapitalleases
12252000000 USD
CY2003Q4 cvs Number Of Competitors Against Whom Putative Actions Are Filed
NumberOfCompetitorsAgainstWhomPutativeActionsAreFiled
2 competitor
CY2003Q4 cvs Number Of Pharmacies Filing Putative Action
NumberOfPharmaciesFilingPutativeAction
2 pharmacy
CY2013Q2 cvs Other Comprehensive Income Loss Before Reclassification Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationNetOfTax
-16000000 USD
cvs Other Comprehensive Income Loss Before Reclassification Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationNetOfTax
15000000 USD
CY2014Q2 cvs Other Comprehensive Income Loss Before Reclassification Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationNetOfTax
6000000 USD
cvs Other Comprehensive Income Loss Before Reclassification Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationNetOfTax
-18000000 USD
CY2014Q2 cvs Segment Reporting Information Revenues Recorded By More Than One Reporting Segment
SegmentReportingInformationRevenuesRecordedByMoreThanOneReportingSegment
1200000000 USD
cvs Segment Reporting Information Revenues Recorded By More Than One Reporting Segment
SegmentReportingInformationRevenuesRecordedByMoreThanOneReportingSegment
2300000000 USD
CY2013Q2 cvs Segment Reporting Information Revenues Recorded By More Than One Reporting Segment
SegmentReportingInformationRevenuesRecordedByMoreThanOneReportingSegment
1100000000 USD
cvs Segment Reporting Information Revenues Recorded By More Than One Reporting Segment
SegmentReportingInformationRevenuesRecordedByMoreThanOneReportingSegment
2000000000 USD
cvs Yearthe Last Lease Expires
YeartheLastLeaseExpires
2026
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000064803
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1158126112 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
CVS CAREMARK CORPORATION

Files In Submission

Name View Source Status
0000064803-14-000028-index-headers.html Edgar Link pending
0000064803-14-000028-index.html Edgar Link pending
0000064803-14-000028.txt Edgar Link pending
0000064803-14-000028-xbrl.zip Edgar Link pending
cvs-20140630.xml Edgar Link completed
cvs-20140630.xsd Edgar Link pending
cvs-20140630_cal.xml Edgar Link unprocessable
cvs-20140630_def.xml Edgar Link unprocessable
cvs-20140630_lab.xml Edgar Link unprocessable
cvs-20140630_pre.xml Edgar Link unprocessable
cvs20140630-10q.htm Edgar Link pending
cvs20140630ex311.htm Edgar Link pending
cvs20140630ex312.htm Edgar Link pending
cvs20140630ex321.htm Edgar Link pending
cvs20140630ex322.htm Edgar Link pending
exhibit1012014amendedandre.htm Edgar Link pending
exhibit1012014amended_image1.gif Edgar Link pending
exhibit151q214eyconsent.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending